Top-Rated StocksTop-RatedNASDAQ:TMDX TransMedics Group (TMDX) Stock Price, News & Analysis $127.15 -2.82 (-2.17%) (As of 10/17/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About TransMedics Group Stock (NASDAQ:TMDX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get TransMedics Group alerts:Sign Up Key Stats Today's Range$125.81▼$131.8850-Day Range$127.15▼$176.1152-Week Range$36.42▼$177.37Volume1.01 million shsAverage Volume833,526 shsMarket Capitalization$4.24 billionP/E Ratio3,178.75Dividend YieldN/APrice Target$174.30Consensus RatingBuy Company OverviewTransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.Read More… Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover TransMedics Group Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks74th Percentile Overall ScoreTMDX MarketRank™: TransMedics Group scored higher than 74% of companies evaluated by MarketBeat, and ranked 273rd out of 1,012 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingTransMedics Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 9 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageTransMedics Group has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about TransMedics Group's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth50.82% Earnings GrowthEarnings for TransMedics Group are expected to grow by 50.82% in the coming year, from $1.22 to $1.84 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of TransMedics Group is 3,178.75, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 133.32.Price to Earnings Ratio vs. SectorThe P/E ratio of TransMedics Group is 3,178.75, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 139.15.Price to Book Value per Share RatioTransMedics Group has a P/B Ratio of 30.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about TransMedics Group's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted18.05% of the outstanding shares of TransMedics Group have been sold short.Short Interest Ratio / Days to CoverTransMedics Group has a short interest ratio ("days to cover") of 6.1.Change versus previous monthShort interest in TransMedics Group has recently increased by 9.45%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldTransMedics Group does not currently pay a dividend.Dividend GrowthTransMedics Group does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted18.05% of the outstanding shares of TransMedics Group have been sold short.Short Interest Ratio / Days to CoverTransMedics Group has a short interest ratio ("days to cover") of 6.1.Change versus previous monthShort interest in TransMedics Group has recently increased by 9.45%, indicating that investor sentiment is decreasing significantly. News and Social Media1.5 / 5News Sentiment0.76 News SentimentTransMedics Group has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for TransMedics Group this week, compared to 6 articles on an average week.Search InterestOnly 13 people have searched for TMDX on MarketBeat in the last 30 days. This is a decrease of -7% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added TransMedics Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, TransMedics Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $9,981,907.00 in company stock.Percentage Held by InsidersOnly 7.00% of the stock of TransMedics Group is held by insiders.Percentage Held by Institutions99.67% of the stock of TransMedics Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about TransMedics Group's insider trading history. Receive TMDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TransMedics Group and its competitors with MarketBeat's FREE daily newsletter. Email Address TMDX Stock News HeadlinesTamer I. Khayal Sells 2,958 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) StockOctober 4, 2024 | insidertrades.comWaleed H. Hassanein Sells 8,625 Shares of TransMedics Group, Inc. (NASDAQ:TMDX) StockSeptember 20, 2024 | insidertrades.comThese LIVE trade signals would have dished out how much money? 51 LIVE trade signals…and you won’t believe how much some of my members could have grown their account! Seriously, for the first “beta testers” of this weekly income strategy…. The returns were JAW-DROPPING. How much could they have grown their $10k starting account?October 18, 2024 | DTI (Ad)TransMedics Group, Inc. (NASDAQ:TMDX) CEO Waleed H. Hassanein Sells 8,625 SharesSeptember 18, 2024 | insidertrades.comTransMedics Group: This Could Be One Of The Biggest Moats In A DecadeOctober 16 at 8:38 PM | seekingalpha.comTransMedics to Report Third Quarter 2024 Financial Results on October 28, 2024October 15 at 4:05 PM | prnewswire.comTransMedics Group Inc (TMDX) Q2 2024 Earnings Call Highlights: Record Revenue Growth and ...October 11, 2024 | finance.yahoo.com2 No-Brainer Healthcare Stocks to Buy With $200 Right NowOctober 10, 2024 | fool.comSee More Headlines TMDX Stock Analysis - Frequently Asked Questions How have TMDX shares performed this year? TransMedics Group's stock was trading at $78.93 on January 1st, 2024. Since then, TMDX stock has increased by 61.1% and is now trading at $127.15. View the best growth stocks for 2024 here. How were TransMedics Group's earnings last quarter? TransMedics Group, Inc. (NASDAQ:TMDX) issued its quarterly earnings data on Wednesday, July, 31st. The company reported $0.35 EPS for the quarter, beating the consensus estimate of $0.21 by $0.14. TransMedics Group's quarterly revenue was up 117.7% compared to the same quarter last year. When did TransMedics Group IPO? TransMedics Group (TMDX) raised $75 million in an IPO on Thursday, May 2nd 2019. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. Morgan Stanley and J.P. Morgan served as the underwriters for the IPO and Cowen and Company and Canaccord Genuity were co-managers. Who are TransMedics Group's major shareholders? Top institutional investors of TransMedics Group include Handelsbanken Fonder AB (0.19%), Creative Planning (0.03%), Park Avenue Securities LLC (0.03%) and SG Americas Securities LLC (0.03%). Insiders that own company stock include James R Tobin, Waleed H Hassanein, Miriam Provost, Stephen Gordon, Nicholas Corcoran, Tamer I Khayal, John F Carey, David Weill, Anil P Ranganath, Edward M Basile, Stephanie Lovell, Laura Damme and Edwin M Kania Jr. View institutional ownership trends. How do I buy shares of TransMedics Group? Shares of TMDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of TransMedics Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that TransMedics Group investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Invesco QQQ (QQQ), Broadcom (AVGO), Arista Networks (ANET) and CrowdStrike (CRWD). Company Calendar Last Earnings7/31/2024Today10/17/2024Next Earnings (Confirmed)10/28/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:TMDX CUSIPN/A CIK1756262 Webwww.transmedics.com Phone(978) 552-0900FaxN/AEmployees210Year FoundedN/APrice Target and Rating Average Stock Price Target$174.30 High Stock Price Target$208.00 Low Stock Price Target$127.00 Potential Upside/Downside+37.1%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)$0.04 Trailing P/E Ratio3,178.75 Forward P/E Ratio104.22 P/E GrowthN/ANet Income$-25,030,000.00 Net Margins0.84% Pretax Margin0.41% Return on Equity15.98% Return on Assets3.41% Debt Debt-to-Equity Ratio2.67 Current Ratio9.37 Quick Ratio8.48 Sales & Book Value Annual Sales$241.62 million Price / Sales17.56 Cash Flow$0.13 per share Price / Cash Flow943.07 Book Value$4.20 per share Price / Book30.27Miscellaneous Outstanding Shares33,360,000Free Float31,024,000Market Cap$4.24 billion OptionableOptionable Beta1.99 The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:TMDX) was last updated on 10/18/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredAdd $2T of Potential Magic to Your PortfolioRevolutionizing a whole $2T entertainment and licensing industry might sound like the stuff of fairytales. But...Elf Labs | SponsoredEquation for Profits: Volatility = OpportunityFREE Intro to Options Class Online Tonight Prosper Trading Academy | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredA Totally New ‘Income Coin’Buckle up… Because this might shatter everything you thought you knew about "income trading." In fact, i...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TransMedics Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TransMedics Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.